Our clients are ambitious, growing and leaders in their field – just like us.
Whether you’re a start-up or an established global organisation – we have the team, the time and the experience to help you navigate even the most complicated commercial challenges facing your business.
With offices in the UK and Europe and clients around the world, we can help you thrive in a global economy.
Clients choose us because we understand their business, we’ve been in their shoes, and together we find solutions. It is our in-depth industry knowledge and down-to-earth delivery that means you can trust us to provide the best possible advice.
- Brand Development
- Brexit: Challenges and Opportunities
- Competition, Regulatory and Trade
- Condor: Alternative Legal Solutions
- Corporate Crime
- Dispute Resolution
- Employment, Pensions and Incentives
- Financial Services
- Intellectual Property
- Inward Investment
- Medical Negligence
- Personal Injury
- Private Client
- Public and Regulatory
- Real Estate
- Tax and Structuring
- Technology, Outsourcing and Privacy
EU institutions post-Brexit as the UK Government stands to take control of £470 million annually
Fieldfisher has undertaken an analysis of the UK's budgetary contribution to the administrative costs of 67 EU institutions and agencies.
Transposing the Bureaucracy of the EU into the UK Civil Services
Clause 2(1) of the European Union (Withdrawal) Bill 2017-19 (known as the Great Repeal Bill), which passed its second reading in the House of Commons on 11 September, provides that EU-derived domestic legislation, as it has effect in domestic law immediately before exit day, continues to have effect in domestic law on and after exit day.
Chapter 2 in the Tale of Brexit, Medical Devices and MDR / IVDR: Suggestions for coping with the regulatory uncertainty
The UK is facing a perfect regulatory storm with the timing for Brexit and the staggered application of the various provisions of MDR and IVDR, with most of the provisions of the latter not being brought onto the UK statute book by the current draft of the EU (Withdrawal) Bill. Without clear guidance from the UK government on this point, it is difficult for medical device companies to know what to do to ensure that they might be able to continue to sell their devices on the market in the UK and the EU27 after Brexit. This post provides some ideas for how to cope with the uncertainty, ensuring you might prepare for the most favourable position in readiness for Brexit (scroll to section 4. at the bottom if you want the advice without the theory).
Brexit & the environment - Update
The Environment Secretary is hedging his bets on a Brexit consensus for the environment by announcing plans for a new, independent statutory body to enforce environmental standards in England after Brexit.
Alex Campbell and Gonzalo Fernandez are mentioned in 'Fieldfisher has been approved as the first professional member of TACT (The Association of Corporate Trustees)'
Tom Pick published 'Manufacturers of Luxury Products May Ban Online Sales of Authorised Distributors Through Third-Party Platforms'
Anne-Laure-Hélène des Ylouses and Clément Hubert published 'Les nouvelles obligations des plateformes numériques à compter du 1er janvier 2018'
Olivier Lantrès and Sébastien Pradeau are mentioned in 'Plus de 80 industriels de la santé présents à la matinale de Fieldfisher portant sur l'actualité de la loi "anti-cadeaux"'
Graeme Nuttall OBE, Neil Palmer and Bethany Walters are mentioned in 'Employees of world renowned architect and Fieldfisher client AHMM have become majority owners'
Anne-Laure-Hélène des Ylouses published 'ALERTE COMPLIANCE : Faut-il vous déclarer comme représentant d'intérêts?'
John Cassels, George McLellan and Anatol Poyer-Sleeman are mentioned in 'EU institutions post-Brexit as the UK Government stands to take control of £470 million'